How poverty policies may affect Alzheimer's and related dementias
Official title: Bridging Social Epidemiology and Policy for ADRD Prevention: Effects of Poverty Alleviation Policies on Alzheimer's Disease and Related Dementias Risk and Disparities
Funded at University of California Los Angeles · NIH-11575639 · Data updated 2026-11-12
This project looks at whether social policies that reduce poverty can lower the risk of Alzheimer's disease and related dementias.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project start | May 1, 2025 |
| Project end | July 31, 2029 |
| Funding year | 2026 |
| Award (this year) | $249,000 |
| NIH project number | 4R00AG088369-03 |
| Project ID | NIH-11575639 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults, especially older adults, in the U.S. whose communities may be affected by poverty-related policies.
✕Less likely to help
Individuals without exposure to states or programs studied may see limited direct benefit.
What this research studies
Poverty is linked to higher risk of Alzheimer’s and related dementias. The research will use big data from health surveys and Medicare to track dementia trends in recent years. By examining how programs like SNAP influence dementia rates, the study aims to connect poverty-reduction efforts with brain health in communities. The work will use statistical methods to compare changes over time and across states to uncover potential policy-related impacts.
Why it matters
Potential benefit: If successful, findings could inform policies that help reduce dementia risk at the population level.
How similar studies have gone: Past work links social determinants to brain health, with growing evidence that policy changes can affect health outcomes.
Where this research is happening
-
University of California Los Angeles
Los Angeles, United States Active
Researchers
- Principal investigator: Chen, Ruijia — University of California Los Angeles
- Study coordinator: Chen, Ruijia
Related research
Other NIH-funded projects on the same topics.
-
Understanding how brain activity changes may drive Alzheimer’s disease progression in a mouse model
Researchers are testing how changes in brain signals and protein cleanup processes affect the development of Alzheimer’s disease in mice.
-
Thiamine-boosting therapy for Alzheimer’s: understanding how benfotiamine may reduce harmful AGE in DP patients
A medication-based approach using high-dose vitamin B1 (benfotiamine) is studied to help people with Alzheimer's by reducing harmful sugar-related molecules.
-
Non-invasive tears biomarker for early Alzheimer's in LMICs
A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.
-
Turning APOE4 into protective APOE2 or APOE3Christchurch to help with Alzheimer’s
A patient-facing explanation of a treatment idea that aims to change a genetic risk factor for Alzheimer's disease in the brain.
-
Telomerase in Alzheimer’s Disease: how aging biology could influence memory and brain health
Researchers are exploring a new brain-aging mechanism linked to telomerase, with potential to slow or modify Alzheimer’s disease in people and improve cognitive function.
-
Biomarkers of Alzheimer’s Disease: Sensory, Motor, and Cognitive Clues
Researchers are testing simple sensory and movement tasks to find early signs of Alzheimer’s disease so they can diagnose and treat people sooner.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.